跳至主要内容
临床试验/NCT06418048
NCT06418048招募中不适用

Prospective Registry and Biobank of Patients With Infectious Diseases

IRCCS San Raffaele1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2024年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10,000
试验地点
1
主要终点
Treatment of specific infectious diseases

研究概览

简要总结

Prospective observational study designed to describe the clinical, laboratory, imaging, microbiological characteristics and treatment of specific infectious diseases, with the addition of a dedicated biobank.

详细描述

The registry would provide a comprehensive database including a vast population of patients with infectious diseases, favoring the analysis of clinical, laboratory and therapeutic data of specific infectious conditions.

Specific infectious diseases of major interest include, among others:

  • Bloodstream infections (i.e.: infectious syndromes manifesting with bacteremia)
  • Endovascular infections (i.e.: infective endocarditis, cardiovascular implantable electronic device infections, vascular graft infections, etc.)
  • Central nervous system infections (i.e.: meningitis, encephalitis, cerebral abscess, ventricular shunts infections, etc.)
  • Bone and joint infections (i.e.: osteomyelitis, spondylodiscitis, prosthetic joint infections, etc.)
  • Sexually transmitted infections (i.e.: gonococcal and non-gonococcal urethritis, proctitis, epididymo-orchitis, syphilis, etc.)
  • HIV infection
  • Emerging and re-emerging infectious diseases.

General objectives of the study for each specific infectious disease include:

  • description and evolution over time of clinical and laboratory characteristics of patients with specific infectious diseases;
  • description and evolution over time of microbial isolates, including antimicrobial susceptibility testing;
  • description and evolution over time of treatment employed in patients with specific infectious diseases;
  • evaluation of predictive factors for treatment success and mortality in patients with specific infectious diseases;
  • description, evaluation and prognostic impact of microbial, immunological and inflammatory biomarkers.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with clinically suspected or microbiologically documented infectious diseases (bacterial, viral, fungal or parasitic);
  • At least 18 years of age or older;
  • Able to provide informed consent;
  • Participants who are unable to understand the study protocol or are unable to give informed consent, but have a legal representative

排除标准

  • - Participants who are unable to understand the study protocol or are unable to give informed consent, and have no legal representative.

结局指标

主要结局

Treatment of specific infectious diseases

时间窗: 6 months (with the exception of people living with HIV)

Describe the antimicrobial treatment of specific infectious diseases

Clinical characteristics of specific infectious diseases

时间窗: 6 months (with the exception of people living with HIV)

Describe the clinical presentation of specific infectious diseases, by means of Sequential Organ Failure Assessment (SOFA) score (minimum 0 - maximum 24; higher scores linked to worse outcome).

Microbiological characteristics of specific infectious diseases

时间窗: 6 months (with the exception of people living with HIV)

Describe the microbiological characteristics of specific infectious diseases. Specifically: * Identification of the causative organisms * Antimicrobial susceptibility testing results * Mechanism of resistance

次要结局

  • Need for ICU(6 months (with the exception of people living with HIV))
  • Overall mortality(6 months (with the exception of people living with HIV))
  • Infection-attributable mortality(6 months (with the exception of people living with HIV))
  • Predictive factors of microbiological cure(6 months (with the exception of people living with HIV))
  • Predictive factors of clinical cure(6 months (with the exception of people living with HIV))
  • Neurological impairment(6 months (with the exception of people living with HIV))
  • Development of comorbidities(6 months (with the exception of people living with HIV))
  • Need for surgical intervention or other procedures(6 months (with the exception of people living with HIV))
  • Functional impairment(6 months (with the exception of people living with HIV))
  • Development of drug toxicity(6 months (with the exception of people living with HIV))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Castagna Antonella

Full Professor

Ospedale San Raffaele

研究点 (1)

Loading locations...

相似试验